IP Verse

Cells For Immunotherapy Engineered For Targeting Antigen Present Both On Immune Cells And Pathological Cells - EP3105317

PATENT ANALYSIS

Patent Details

Grant Date
Sep 19, 2018
Company
CELLECTIS
Oppositions

JAMES POOLE LIMITED

SCHIWECK WEINZIERL KOCH PATENTANWALTE PARTNERSCHAFT MBB

More patents of Cellectis

EP2997141

EP3116902

EP3189073

Want to monitor this patent?

Feel free to send us a message here and we will get back to you